Wednesday Aug 10, 2022
Low-and middle-income countries: Their influence on global COPD guidelines
This week's guest on the Medical Insider COPD podcast is Professor Eric Bateman, a Chest Physician and Professor of Respiratory Medicine at the University of Cape Town, South Africa. Join him and Dr Richard Russell as they discuss the barriers impeding implementation of global COPD recommendations in low- and middle-income countries (LMICs) and how global guidelines might better cater to LMICs,1,2 highlighting the importance of treatment accessibility worldwide. 1,3 Dr Russell will then present important takeaways from a new and exciting publication on the use of diaphragmatic movement as a prognostic marker of COPD. 4 This will be followed by a dive into social media, where patients with COPD are discussing the safety of resuming travelling. Don’t miss out on this exciting episode of the Medical Insider COPD and remember to subscribe!
1. Hurst JR, et al. Ann Am Thorac Soc 2021;18:1269–1277;
2. Global Initiative for Chronic Obstructive Lung Disease. 2022 Update. Available at: here . Last accessed: July 2022;
3. Brakema EA, et al. NPJ Prim Care Respir Med 2019;29:6;
4. Mekov E, et al. Int J Chron Obstruct Pulmon Dis 2022;17:1041–1050.
Disclosures
Professor Eric Bateman
Eric Bateman has received honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Hikma Pharma, Menarini, Novartis, Regeneron and Sanofi Genzyme. He also reports consulting fees from AstraZeneca, Novartis, Regeneron and Sanofi Genzyme in the past 3 years.
Bios:
Professor Eric Bateman Professor Eric Bateman is the founder and former director of the University of Cape Town Lung Institute and former Head of the Division of Pulmonology at the University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa. His primary research interests include the pharmacology and management of asthma and COPD, as well as community-based interventions to improve the care of patients. He has published more than 370 papers in international peer-reviewed journals. He is a member of both the Board and the Science Committee of the Global Initiative for Asthma and has served as President of the South African Thoracic Society. He has received numerous awards including the President’s Award from the European Thoracic Society for his global contribution to Respiratory Medicine (2012), South Africa’s National Science and Technology Forum BHP-Billiton Lifetime Award for Outstanding Contribution to Science, Engineering, Technology and Innovation (2014) and the World Lung Health Award from the American Thoracic Society (2018). |
This series of podcasts are intended for healthcare professionals only.
The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.
Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.